Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial

NCT00378196 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00378196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00378196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2006
Completion date
December 31, 2008
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

telangiectasia